Abstract

Background: Fenugreek, an ancient herb has been known for its culinary and medicinal value in Indian Subcontinent. Its seeds, rich in fibers and phytochemical compounds, have been investigated for their hypoglycemic and multiple benefits. This study was thus undertaken to assess the anti-hyperglycemic effect of fenugreek seeds in patients of Type 2 Diabetes Mellitus (DM) as add-on therapy with metformin. Methods: An open-labelled comparative study of 12 weeks duration was conducted on patients (randomly divided in 2 groups of 30 each) of Type 2 DM. Group 1 was given metformin 500 mg twice a day while group 2 was given 500 mg of metformin along with fenugreek seed powder capsule,1 gm thrice a day. Weekly evaluation for fasting and post-prandial blood sugar was done. HbA1c estimation was done at the beginning and at the end of the study. Student’s t-test (paired and unpaired) was applied for statistical analysis. Results: After 12 weeks of treatment, there was significant fall in fasting, as well as postprandial blood sugar and HbA1c levels in group 1 and group 2. However this improvement was statistically more significant in group 2 when compared to group 1. Conclusions: This study shows the beneficial effects of fenugreek seeds on glycemic profile in patients of Type 2 DM and can be used as an add-on therapy with metformin in management of Type 2 DM.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call